Objective: Neuropsychological tests undergo periodic revision intended to improve psychometric properties, normative data, relevance of stimuli, and ease of administration. In addition, new tests are developed to evaluate psychological and neuropsychological constructs, often purporting to improve evaluation effectiveness. However, there is limited professional guidance to neuropsychologists concerning the decision to adopt a revised version of a test and/or replace an older test with a new test purporting to measure the same or overlapping constructs. This paper describes ethical and professional issues related to the selection and use of older versus newer psychological and neuropsychological tests, with the goal of promoting appropriate test selection and evidence-based decision making.
Method: Ethical and professional issues were reviewed and considered.
Conclusions: The availability of a newer version of a test does not necessarily render obsolete prior versions of the test for purposes that are empirically supported, nor should continued empirically supported use of a prior version of a test be considered unethical practice. Until a revised or new test has published evidence of improved ability to help clinicians to make diagnostic determinations, facilitate treatment, and/or assess change over time, the choice to delay adoption of revised or new tests may be viewed as reasonable and appropriate. Recommendations are offered to facilitate decisions about the adoption of revised and new tests. Ultimately, it is the responsibility of individual neuropsychologists to determine which tests best meet their patients' needs, and to be able to support their decisions with empirical evidence and sound clinical judgment.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/13854046.2017.1422277 | DOI Listing |
Sci Rep
January 2025
Department of Psychology, University of Oregon, Eugene, OR, USA.
Situational factors can influence cognitive performance and should be considered for conducting cognitive assessments. The objective of this project was to develop a checklist for Cognitive Assessment Requirements (CARE) to identify these situational factors before conducting cognitive assessments and account for them. This study employed a four-round Delphi approach involving 22 experts to identify situational factors that can impact cognitive assessment results.
View Article and Find Full Text PDFAten Primaria
January 2025
Unitat de Suport a la Recerca Metropolitana Nord, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Mataró, España; Institut d'Investigació Germans Trias i Pujol Research Institute (IGTP), Badalona, España; Departamento de Medicina, Facultad de Medicina, Universitat de Girona, Gerona, España.
The objective was to describe the experiences of people living with neuropsychological symptomatology associated with long-covid, as well as identifying the barriers they encounter in their daily lives and the strategies they develop to deal with them. This is a descriptive qualitative study following an interpretative phenomenological perspective wich was held in Primary Care cin the Northern Metropolitan Area of Barcelona and the Germans Trias i Pujol University Hospital (Badalona, Spain). A total of 34 adults with any persistent neuropsychological symptoms of covid-19 (>12 weeks since disease onset) participated.
View Article and Find Full Text PDFCells
January 2025
Translational Brain Research Laboratory, The Feinstein Institutes for Medical Research, Manhasset, NY 11030, USA.
Despite the presentation of similar psychological symptoms, psychological dysfunction secondary to brain injury exhibits markedly lower treatment efficacy compared to injury-independent psychological dysfunction. This gap remains evident, despite extensive research efforts. This review integrates clinical and preclinical evidence to provide a comprehensive overview of the neurobiological mechanisms underlying neuropsychological disorders, focusing on the role of key brain regions in emotional regulation across various forms of brain injuries.
View Article and Find Full Text PDFJ Neurol Sci
January 2025
Third Neurology Unit and Motor Neuron Disease Centre, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Background: Motor neuron disease (MND) is a heterogeneous neurodegenerative disorder, with nearly 50 % of patients exhibiting cognitive and behavioral symptoms in addition to motor decline. Anxiety and depression, though frequently observed in this population, have been understudied in relation to motor and extra-motor profiles.
Objectives: Our study addresses this gap by validating the Hospital Anxiety and Depression Scale for Motor Neuron Disease (HADS-MND) and investigating the interplay between mood, clincial, and frontotemporal symptoms in a large sample of MND patients.
Clin Auton Res
January 2025
Neuro-E-Motion Research Team, Department of Psychology, Faculty of Health Sciences, University of Deusto, 48007, Bilbao, Spain.
Purpose: The aim of the study is to analyze and compare the cognitive profile between 59 patients with long-COVID [LC; 30 of them with and 29 without a positive coronavirus disease 2019 (COVID-19) confirmatory test] and 31 patients with postural orthostatic tachycardia syndrome (POTS) and a matched group of 39 healthy control participants.
Methods: Participants were examined on a battery of neuropsychological tests, including verbal memory, visuospatial abilities, attention, processing speed, verbal fluency, working memory, and visual memory. Anxious-depressive symptomatology was also analyzed and then controlled for possible influence on cognitive performance.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!